Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2010
11/04/2010US20100279360 Sso7-Polymerase Conjugate Proteins
11/04/2010US20100279350 C-type lectin polypeptide, polynucleotide and methods of making and use thereof
11/04/2010US20100279348 Yeast strains for protein production
11/04/2010US20100279347 Polymyxin synthetase and gene cluster thereof
11/04/2010US20100279346 Compositions and Methods for Improved Protein Production
11/04/2010US20100279345 Aut0-inducible sodium phosphate symporter promoter from pichia pastoris and method for producing recombinant protein using it
11/04/2010US20100279323 Method for predicting response to epidermal growth factor receptor-directed therapy
11/04/2010US20100279313 Novel secreted immunomodulatory proteins and uses thereof
11/04/2010US20100279293 Methods and compositions for identifying increased risk of developing fragile x-associated disorders
11/04/2010US20100279292 MicroRNA Expression in Human Peripheral Blood Microvesicles and Uses Thereof
11/04/2010US20100279291 Gene silencing of the brother of the regulator of imprinted sites (boris)
11/04/2010US20100279287 Compositions and methods useful for site-directed recombination in plants
11/04/2010US20100279284 Method for selecting hop line and breeding marker and primer set used for selecting hop line
11/04/2010US20100279273 Nucleic acid sequences for the amplification and detection of respiratory viruses
11/04/2010US20100278970 Trichoderma reesei alpha-amylase enhances saccharification of corn starch
11/04/2010US20100278937 Compositions and methods to prevent and/or treat cancer with pa-card
11/04/2010US20100278871 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
11/04/2010US20100278868 Codon-Optimized Dna Molecules Encoding the Receptor Binding Domains of Clostridium Difficile Toxins A and B, and Methods of Use Thereof
11/04/2010US20100278865 Production and use of epitope-tagged hepatitis c virus particle
11/04/2010US20100278861 Methods and compositions for predicting emergence and expansion of drug resistant strains of influenza virus
11/04/2010US20100278857 Dendritic Cell Binding Proteins and Uses Thereof
11/04/2010US20100278842 Anti-ephb2 antibodies and methods using same
11/04/2010US20100278841 DOWN-REGULATION OF MORTALIN BY siRNA
11/04/2010US20100278834 Antibodies against h5n1 strains of influenza a virus
11/04/2010US20100278832 Anti-bst2 antibody
11/04/2010US20100278827 Concatameric immunoadhesion molecule
11/04/2010US20100278826 Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins
11/04/2010US20100278821 N-cadherin: target for cancer diagnosis and therapy
11/04/2010US20100278820 Reagents that bind ccx-ckr2
11/04/2010US20100278819 Streptococcus pneumoniae vaccines
11/04/2010US20100278818 Antibody specific for the Tn antigen for the treatment of cancer
11/04/2010US20100278809 Inhibitors of MRP4 for the Treatment of Vascular Disorders
11/04/2010US20100278800 Stem cell factor-like proteins and uses thereof
11/04/2010US20100278797 Pharmaceutical Composition and Method for Regulating Abnormal Cellular Proliferation
11/04/2010US20100278791 Adeno-associated virus serotype i nucleic acid sequences, vectors and host cells containing same
11/04/2010US20100278774 Fusion molecules and il-15 variants
11/04/2010US20100278773 Chimeric flavivirus vaccines
11/04/2010US20100278740 Streptococcus pneumoniae proteins and nucleic acid molecules
11/04/2010DE102009012169B3 Vorrichtung und Verfahren zum Herstellen eines Replikats oder eines Derivats aus einem Array von Molekülen und Anwendungen derselben Apparatus and method for producing a replica or a derivative of an array of molecules and applications thereof
11/04/2010CA2760518A1 Epigenetic marker for the identification of natural killer cells
11/03/2010EP2246443A1 Antisense modulation of PTP1B expression
11/03/2010EP2246428A1 Modified trna containing non-natural nucleotide and use thereof
11/03/2010EP2246422A1 Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof
11/03/2010EP2246416A1 Mutated Abl kinase domains
11/03/2010EP2246358A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
11/03/2010EP2246357A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
11/03/2010EP2245041A1 Compositions and methods for detecting juvenile renal dysplasia or calcium oxalate stones in dogs
11/03/2010EP2245040A2 Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods
11/03/2010EP2245039A2 Optimized methods for delivery of dsrna targeting the pcsk9 gene
11/03/2010EP2244990A1 Sulfurization agent and its use
11/03/2010EP1567540B1 Cftr allele detection assays
11/03/2010EP1301625B1 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/03/2010EP1159457B1 T cell receptor vbeta - dbeta - jbeta) sequence and methods for its detection
11/03/2010EP0961837B1 Chimeric antisense oligonucleotides
11/03/2010CN101875930A Method for rapidly and efficiently extracting total RNA of rice tissue
11/03/2010CN101875924A Improved SS07-polymerase conjugate proteins
11/03/2010CN101215604B Kit for detecting human galactophore globin mRNA expression quantity and application thereof
11/02/2010US7825237 Oligonucleotides and analogs labeled with energy transfer dyes
11/02/2010US7825236 Phosphodiesterase inhibitor for treatment and prevention of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis
11/02/2010US7825235 Modulation of diacylglycerol acyltransferase 2 expression
11/02/2010US7825233 Optimizing expression of active Botulinum Toxin type E
11/02/2010US7825232 Sequence for improving expression of nucleic acid
11/02/2010US7825231 Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
11/02/2010US7825230 Human microRNA targets in HIV genome and a method of identification thereof
11/02/2010US7825229 MiRNAs; diagnosis, prognosis, and treatments; drug screening; linear amplification and labeling for hybridization techniques like Luminex and Microarray analysis; gene expression inhibition
11/02/2010US7825228 Bone mineralization proteins, DNA, vectors, expression systems
11/02/2010US7825218 Solubilization and purification of a target protein fused to a mutant maltose-binding protein
11/02/2010US7825215 Substituted nucleic acid mimics
11/02/2010US7825101 introducing into cell a double stranded siNA that cleaves MLCK RNA, wherein each strand of siNA molecule is 19-25 nucleotides in length and one strand of siNA molecule comprises a region having a nucleotide sequence having complementarity to MLCK RNA for siNA molecule to direct cleavage of MLCK RNA
11/02/2010US7825100 sequence complementary to GRP78 forms a special hair-pin structure inside cancer cells to specifically and effectively inhibit GRP78 expression and then inhibit the canceration process, including the growth, migration, invasion, and metastasis of cancer
11/02/2010US7825099 Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
11/02/2010US7825069 Normalization; aggregation; mass spectrometry
11/02/2010US7824917 Method of detecting nucleic acid by using nucleic acid microarray
11/02/2010US7824908 Expression vector comprising nucleotide sequences coding toxoplasma major surface antigen p30 for use in generation of immunoglobulin for use in prevention and treatment of parasitic infection
11/02/2010US7824900 DNA screening device which utilizes electrode immobilized nucleotide sequences to identify preferential nucleotide sequences
11/02/2010US7824898 Enzymatic polypeptide comprising halogenase activity for use in production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters; bioremediation; pollution control
11/02/2010US7824895 Phytases, nucleic acids encoding them and methods for making and using them
11/02/2010US7824894 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
11/02/2010US7824889 Digital amplification
11/02/2010US7824887 Reversible terminator nucleotides and methods of use
11/02/2010US7824863 Nucleic acid labeling methods
11/02/2010US7824862 for detection and/or identification of genetic polymorphism such as those associated with human disease and permit the identification of pathogens; use of probes that are designed to interact with non-contiguous regions of complementarity
11/02/2010US7824861 Method for quantitative analysis of transcripts with nucleotide polymorphism at specific site
11/02/2010US7824860 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
11/02/2010US7824859 generating a signal indicative of the presence of a target nucleic acid in a sample by forming a cleavage structure through incubating a sample with a probe containing a binding moiety and having a secondary structure that changes upon binding and cleaving the cleavage structure with a nuclease
11/02/2010US7824858 determining the presence of Mycobacterium avium complex nucleic acids in a biological sample by detecting the mig gene of M. avium and the DT1 gene of M. intracellulare and amplifying them
11/02/2010US7824855 Method for selectively separating and purifying RNA and method for separating and purifying nucleic acid
11/02/2010US7824853 Using expression vectors as drug delivery tools in evaluating receptor-ligand interaction; inter-molecular interactions under physiological or near-physiological conditions
11/02/2010US7824852 Controlling; calibration
11/02/2010US7824696 Modified nucleotides for immunotherapy; induce immunology response; consisting of nucleoside methylphosphonate and 2'-O-methyl-ribonucleoside groups
11/02/2010US7824695 recombinant proteins comprise cell recognition moiety that binds alpha 2 macroglobulin receptor, and bioactive moiety (pseudomonas exotoxin), which mediates systemic effect, does not function as immunogen and does not have ADP ribosylating activity
11/02/2010US7824692 homologous immunoreactive thio-disulfide oxidoreductases; fusion proteins; fluorescent, radioactive, or enzymatic labels
11/02/2010CA2341520C Energy transfer dyes
11/02/2010CA2332380C Process and materials for production of glucosamine
11/02/2010CA2181394C Ctla4 mutant molecules and uses thereof
10/2010
10/28/2010WO2010123908A1 Biological specimen collection/transport compositions and methods
10/28/2010WO2010123827A1 Engineered demeter 5-methylcytosine dna glycosylase with improved yield, stability and solubility
10/28/2010WO2010123501A1 Innate immune suppression enables repeated delivery of long rna molecules
10/28/2010WO2010085705A3 Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use
10/28/2010WO2010064146A3 Method for the synthesis of phosphorus atom modified nucleic acids
1 ... 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 ... 899